Medical and Pharmaceutical MIRA Pharma up 27% on ketamine analogue’s preclinical results for chemotherapy pain This pharmaceutical company is also developing a synthetic cannabinoid drug to treat anxiety and cognitive decline Rowan DunneOctober 30, 2024
Cannabis What is HHC: effects, uses, legal status HHC, or hexahydrocannabinol, might be less potent than delta-9 THC but it can still get you high Adeline EeJune 7, 2024
News Cronos continues cash burn with US$161M loss in Q1 With revenue of just US$12.6M in Q1, the Canadian pot firm says it's finally ready to commercialize its synthetic cannabinoids joint venture Jared GnamMay 7, 2021
The weed wire Willow Biosciences to get National Research Council funding Funding will go towards commercialization of rare cannabinoids produced from yeast Michelle GamageSeptember 9, 2020